Posts By :

hkalergis

Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation

Diffusion Pharmaceuticals to Initiate Phase 2 Trial in Patients with Glioblastoma Multiforme Incorporating Innovative Imaging Methodology to Evaluate Tumor Oxygenation 150 150 Diffusion Pharmaceuticals Inc.

CHARLOTTESVILLE, Va., July 26, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc.

https://investors.diffusionpharma.com/News/news-details/2022/Diffusion-Pharmaceuticals-to-Initiate-Phase-2-Trial-in-Patients-with-Glioblastoma-Multiforme-Incorporating-Innovative-Imaging-Methodology-to-Evaluate-Tumor-Oxygenation/default.aspx
Back to top